FOXO4-DRI
FOXO4-DRI (FOXO4 D-Retro-Inverso) is a synthetic, cell-penetrating senolytic peptide designed to selectively induce apoptosis in senescent ("zombie") cells. Tt is investigated in longevity and gerontology research for its potential to clear senescent cells and restore tissue homeostasis.
1. Chemical Structure and Biochemistry
FOXO4-DRI is a modified, retro-inverso isoform of the natural FOXO4 protein domain, fused to an HIV-TAT cell-penetrating sequence.
- Structural Modification: It is synthesized using D-amino acids in reverse sequence order (retro-inverso). Because endogenous proteases recognize L-amino acids, this configuration makes the peptide resistant to enzymatic degradation and significantly extends its biological half-life.
- Cell Permeability: The included TAT-derived tail enables the large peptide to cross cell membranes and reach nuclear targets efficiently.
2. Mechanism of Action
Senescent cells accumulate DNA damage but resist programmed cell death (apoptosis) by upregulating FOXO4, which sequesters p53 in the cell nucleus.
- p53 Nuclear Exclusion: FOXO4-DRI competitively binds to p53 with higher affinity than endogenous FOXO4, displacing p53 from the nucleus into the cytoplasm.
- Selective Apoptosis: Once relocated to the mitochondria in the cytoplasm, p53 triggers the intrinsic caspase-dependent apoptosis pathway, selectively eliminating senescent cells while largely sparing healthy, proliferating cells.
3. Research and Applications
FOXO4-DRI is a prominent experimental tool in cellular senescence and aging biology.
- Tissue Rejuvenation: Preclinical murine studies have investigated its ability to improve renal function, restore fur density, and increase physical fitness in naturally aged and chemotherapy-damaged models.
- Endocrine Aging: Research has also examined its capacity to clear senescent Leydig cells in aged testes to evaluate effects on age-related testosterone decline.
Note: FOXO4-DRI is strictly an experimental research compound and is not approved for human clinical use.